Overview

A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This three-part study will evaluate the pharmacokinetics and bioavailability of intravenous danoprevir with and without low-dose oral ritonavir, and the effect of oral cyclosporine on the pharmacokinetics of intravenous danoprevir with ritonavir in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Cyclosporine
Cyclosporins
Lactams
Ritonavir